Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
Food and Drug Administrations (FDAs) patient-focused drug development initiative
Aetiology of age-associated aneuploidy: a mechanism based on the 'free radical theory of ageing'
Increased blood-brain barrier permeability is observed in the model, which is reduced by inhibition of TGF1
113 Bremelanotide in Premenopausal Women with Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
Developing covalent protein drugs via proximity-enabled reactive therapeutics
Purity: 99% (HPLC verified) Formulation: Lyophilized powder blend Molecular Formula: C62H98N16O22 + C212H350N56O78S + C14H24N6O4Cu + C19H35N5O5 Molecular Weight: 1419.5 + 4963 + 403.9 + 413.5 g/mol CAS Number: 137525-51-0 / 77591-33-4 / 49557-75-7 / 65189-71-1 PubChem CID: 9941957 / 16132341 / 3014738 / 5497159 Research Contents BPC-157 + TB-500 + GHK-Cu + KPV-10 KLOW Blend Overview The BPC-157 + TB-500 + GHK-Cu + KPV-10 Blend is a four-peptide regenerative formulation that combines complementary tissue-repair, anti-inflammatory, and matrix-remodeling compounds in a single lyophilized vial
US$ 23.32
US$ 27.01
US$ 20.74
US$ 20.66
US$ 21.76
US$ 26.33
US$ 20.72
US$ 23.22
